TickerGuard
Buy Day today: Neutral (46) Mixed market breadth · no major macro event
CPIX

Cumberland Pharmaceuticals Inc

Healthcare · Drug Manufacturers - Specialty & Generic

4.70$ +7.8% vs. previous close Closing price · As of: Oct 30, 2026

Ownership

Ownership Structure

Who owns Cumberland Pharmaceuticals Inc (CPIX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 58.1% of the shares are freely tradable; institutional investors hold 18.6%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 18.6%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 41.6%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 58.1%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 4.0%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 15Mio.

Largest Shareholders

Institutions

Institutions CPIX
Name Stake (%) Shares Change (%) Date
Ikarian Capital, LLC 3.36 503,153 -9.0 06/30/2026
Renaissance Technologies Corp 3.19 478,263 +1.6 06/30/2026
Vanguard Capital Management, LLC 2.53 379,478 +4.9 06/30/2026
Dimensional Fund Advisors, Inc. 1.56 233,305 -15.6 06/30/2026
BOOTHBAY FUND MANAGEMENT, LLC 0.75 112,544 -11.9 06/30/2026
Geode Capital Management, LLC 0.72 108,413 -5.1 06/30/2026
Perceptive Advisors LLC 0.65 96,982 -50.8 06/30/2026
Citadel Advisors Llc 0.49 73,391 +341.0 06/30/2026
BlackRock Inc 0.42 63,547 +11.7 06/30/2026

Funds

Funds CPIX
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 1.83 274,814 +0.0 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?